Malignant tumor of lung (disorder)
FRAGMATIC
Year Started: 2007
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.
- Access:
- Open only through collaboration
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | 3 - 6 months |
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Genomic datasets | 3 - 6 months |
| Pathology records | 3 - 6 months |
| Physiological/biochemical measurements | 3 - 6 months |
| Quality indicators | 3 - 6 months |
| Treatment records | 3 - 6 months |
Male
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |
Female
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |
Malignant tumor of pancreas (disorder)
SCALOP
Year Started: 2009
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
- Access:
- Open only through collaboration
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | 3 - 6 months |
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Freezer temperature logs | 3 - 6 months |
| Imaging data | 3 - 6 months |
| Physiological/biochemical measurements | 3 - 6 months |
| Quality indicators | 3 - 6 months |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |
Malignant tumour of oesophagus
NEOSCOPE
Year Started: 2013
A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
- Access:
- Open only through collaboration
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | 3 - 6 months |
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Freezer temperature logs | 3 - 6 months |
| Pathology records | 3 - 6 months |
| Quality indicators | 3 - 6 months |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | N/A | Not applicable | 100% |